Among patients with suspected MIBC, the incorporation of mpMRI for initial staging prior to transurethral resection of ...

Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...

Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Bladder Cancer Diagnostics Market by Test Type, by Stages, by Cancer Type, by End User, and By Region" report has been added to ResearchAndMarkets ...

This vulvar tumour case highlights the need for multidisciplinary care to manage coexisting malignancies and infections.

UGN-102 led to durable responses in low-grade, intermediate-risk bladder cancer, per phase 3 study findings at the 2025 ...

Advancements in diagnostic technologies, including liquid biopsy, fluorescence in situ hybridization (FISH), and next-generation sequencing (NGS), are transforming the field of bladder cancer ...

Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...

It was there that a biopsy uncovered the truth: Armando had Stage 4 metastatic urothelial carcinoma (mUC), also known as advanced bladder cancer. Bladder cancer is a serious, challenging disease ...

Advancements in diagnostic technologies, including liquid biopsy, fluorescence in situ hybridization (FISH), and next-generation sequencing (NGS), are transforming the field of bladder cancer ...

Using the Decipher Bladder test to determine each tumor’s molecular subtype, researchers found that NMIBC patients with ...

Bladder-neck biopsy confirmed a poorly differentiated adenocarcinoma of prostate origin (Figure 2A) with positive immunohistochemical studies for PSA and PROSTATIC ACID PHOSPHATASE (Figure 2B).